pharma · Immunotherapy · Opioid Analgesic Adverse Reaction
Second Affiliated Hospital
Second Affiliated Hospital of Soochow University
Second Affiliated Hospital clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CN
- Employees
- 103
- Programs
- 4
- Drugs
- 11
- Patents
- 0
Second Affiliated Hospital projects
4 ClinicalTrials.gov programs sponsored by Second Affiliated Hospital.
Second Affiliated Hospital has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Cadonilimab
Second Affiliated Hospital of Soochow University
Immunotherapy
1 trial -
ZZ-IT-ICI-HCC 1line-023
Second Affiliated Hospital of Soochow University
Liver Cancer
1 trial -
Vedolizumab
Second Affiliated Hospital of Soochow University
Ulcerative Colitis (UC)
1 trial -
Esketamine, Sulfentanil or/and Remifentanil
Second Affiliated Hospital of Soochow University
Opioid Analgesic Adverse Reaction
1 trial
Frequently asked questions
How many clinical projects does Second Affiliated Hospital have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.